Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).

Giusti-Rodríguez P, Gao J, Gräff J, Rei D, Soda T, Tsai LH.

J Neurosci. 2011 Nov 2;31(44):15751-6. doi: 10.1523/JNEUROSCI.3588-11.2011.

2.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
3.

Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Shukla V, Skuntz S, Pant HC.

Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7. Review.

4.
5.

Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity.

Wang H, Megill A, He K, Kirkwood A, Lee HK.

Neural Plast. 2012;2012:272374. doi: 10.1155/2012/272374. Epub 2012 Jun 26. Review.

6.

Novel lipid signaling pathways in Alzheimer's disease pathogenesis.

Giannopoulos PF, Joshi YB, Praticò D.

Biochem Pharmacol. 2014 Apr 15;88(4):560-4. doi: 10.1016/j.bcp.2013.11.005. Epub 2013 Nov 21. Review.

7.

Cdk5 activity in the brain - multiple paths of regulation.

Shah K, Lahiri DK.

J Cell Sci. 2014 Jun 1;127(Pt 11):2391-400. doi: 10.1242/jcs.147553. Review.

8.

Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Yan R, Fan Q, Zhou J, Vassar R.

Neurosci Biobehav Rev. 2016 Jun;65:326-40. doi: 10.1016/j.neubiorev.2016.03.025. Epub 2016 Apr 1. Review.

PMID:
27044452
9.

Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies.

Ohno M.

Brain Res Bull. 2016 Apr 16. pii: S0361-9230(16)30081-8. doi: 10.1016/j.brainresbull.2016.04.007. [Epub ahead of print] Review.

PMID:
27093940
10.

Dysregulation of protein trafficking in neurodegeneration.

Wang X, Huang T, Bu G, Xu H.

Mol Neurodegener. 2014 Aug 25;9:31. doi: 10.1186/1750-1326-9-31. Review.

11.

The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease.

Joshi YB, Giannopoulos PF, Praticò D.

Trends Pharmacol Sci. 2015 Mar;36(3):181-6. doi: 10.1016/j.tips.2015.01.005. Epub 2015 Feb 20. Review.

12.

Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease.

Saura CA, Parra-Damas A, Enriquez-Barreto L.

Front Cell Neurosci. 2015 Aug 25;9:318. doi: 10.3389/fncel.2015.00318. eCollection 2015. Review.

13.

Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity.

Jang SS, Chung HJ.

Neural Plast. 2016;2016:7969272. doi: 10.1155/2016/7969272. Epub 2016 Feb 25. Review.

14.

The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.

Chu J, Praticò D.

Brain Res Bull. 2016 Mar 19. pii: S0361-9230(16)30053-3. doi: 10.1016/j.brainresbull.2016.03.010. [Epub ahead of print] Review.

PMID:
27005438
15.

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.

Wilkaniec A, Czapski GA, Adamczyk A.

J Neurochem. 2016 Jan;136(2):222-33. doi: 10.1111/jnc.13365. Epub 2015 Oct 14. Review.

PMID:
26376455
16.

Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

Kandimalla R, Reddy PH.

Biochim Biophys Acta. 2016 Apr;1862(4):814-28. doi: 10.1016/j.bbadis.2015.12.018. Epub 2015 Dec 17. Review.

PMID:
26708942
17.

[A new strategy for preventive and functional therapeutic methods for dementia--approach using natural products].

Ohizumi Y.

Yakugaku Zasshi. 2015;135(3):449-64. doi: 10.1248/yakushi.14-00245. Review. Japanese.

18.

Synaptic Cell Adhesion Molecules in Alzheimer's Disease.

Leshchyns'ka I, Sytnyk V.

Neural Plast. 2016;2016:6427537. doi: 10.1155/2016/6427537. Epub 2016 May 3. Review.

19.

The UPR and synaptic dysfunction in neurodegeneration.

Freeman OJ, Mallucci GR.

Brain Res. 2016 Mar 26. pii: S0006-8993(16)30162-7. doi: 10.1016/j.brainres.2016.03.029. [Epub ahead of print] Review.

PMID:
27021956
20.

Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and Neurodegeneration.

Lussier AL, Weeber EJ, Rebeck GW.

Front Cell Neurosci. 2016 Mar 29;10:75. doi: 10.3389/fncel.2016.00075. eCollection 2016. Review.

Items per page

Supplemental Content

Write to the Help Desk